Characterization of a dual <scp>BET</scp>/<scp>HDAC</scp> inhibitor for treatment of pancreatic ductal adenocarcinoma
Xin Zhang(Chinese National Human Genome Center), Jens T. Siveke(German Cancer Research Center)
Cited by 52
Related Papers
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
|Nature Medicine|2015|414
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
|Nature Communications|2022|92
Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
|Molecular Cancer|2017|67